1.
Abinaya D, Rajendran A, Manoharan D, Hari VG, Yelugoti V. Study of mutation profile in myelofibrosis and response to low dose ruxolitinib: a tertiary care experience. Int J Adv Med [Internet]. 2025 Jan. 31 [cited 2025 Nov. 17];12(2):175-9. Available from: https://www.ijmedicine.com/index.php/ijam/article/view/4221